Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer

✍ Scribed by Leighl, Natasha B.; Goss, G.D.; Lopez, P.G.; Burkes, R.L.; Dancey, J.E.; Rahim, Y.H.; Rudinskas, L.C.; Pouliot, J.F.; Rodgers, A.; Pond, G.R.; Shepherd, F.A.

• Book ID: 119319378
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 168 KB
• Volume: 52
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/j.lungcan.2006.02.006